SEC 13F Intelligence

Epoch Investment Partners, Inc. / AZNN

Epoch Investment Partners, Inc.’s Astrazeneca PLC Position

Does Epoch Investment Partners, Inc. own Astrazeneca PLC (AZNN)? Not currently — the last reported position was 827.1K shares worth $76M in Q4 2025; the fund’s latest 13F (Q1 2026) no longer reports it.

Position Value
$76M
Q4 2025
Shares
827.1K
% of Portfolio
+0.43%
Quarters Held
29
position exited

Position History AZNN

Reported value by quarter
Q4 ’18: $229MQ4 ’18Q1 ’19: $196MQ2 ’19: $150MQ3 ’19: $117MQ4 ’19: $109MQ4 ’19Q1 ’20: $96MQ2 ’20: $111MQ3 ’20: $82MQ4 ’20: $74MQ4 ’20Q1 ’21: $65MQ2 ’21: $91MQ3 ’21: $101MQ4 ’21: $159MQ4 ’21Q1 ’22: $172MQ2 ’22: $140MQ3 ’22: $113MQ4 ’22: $119MQ4 ’22Q1 ’23: $111MQ2 ’23: $188MQ3 ’23: $184MQ4 ’23: $190MQ4 ’23Q1 ’24: $191MQ2 ’24: $179MQ3 ’24: $153MQ4 ’24: $133MQ4 ’24Q1 ’25: $147MQ2 ’25: $92MQ3 ’25: $80MQ4 ’25: $76MQ4 ’25filingsflow.com
QuarterSharesValue% of Portfolio
Q4 2025827.1K$76M+0.43%
Q3 20251.04M$80M+0.44%
Q2 20251.32M$92M+0.48%
Q1 20252.00M$147M+0.76%
Q4 20242.03M$133M+0.64%
Q3 20241.96M$153M+0.68%
Q2 20242.29M$179M+0.82%
Q1 20242.82M$191M+0.85%
Q4 20232.82M$190M+0.86%
Q3 20232.72M$184M+1.17%
Q2 20232.62M$188M+1.09%
Q1 20231.60M$111M+0.66%
Q4 20221.75M$119M+0.71%
Q3 20222.06M$113M+0.74%
Q2 20222.12M$140M+0.82%
Q1 20222.59M$172M+0.84%
Q4 20212.73M$159M+0.81%
Q3 20211.68M$101M+0.56%
Q2 20211.52M$91M+0.49%
Q1 20211.31M$65M+0.30%
Q4 20201.48M$74M+0.34%
Q3 20201.50M$82M+0.41%
Q2 20202.10M$111M+0.57%
Q1 20202.16M$96M+0.58%
Q4 20192.18M$109M+0.47%
Q3 20192.63M$117M+0.53%
Q2 20193.63M$150M+0.68%
Q1 20194.84M$196M+0.86%
Q4 20186.03M$229M+1.06%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Epoch Investment Partners, Inc.’s full portfolio or all institutional holders of AZNN.